Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase EARLY_PHASE1 5Phase 4 4Phase NA 3Phase 1/2 2Phase 1 2Phase 3 1

Status

Completed 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Polycystic Ovary Syndrome 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Insulin Resistance 1Inflammation 1Hyperinsulinism 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Pioglitazone × Clear all
NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT05753657 2023-03-03

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Rambam Health Care Campus

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Hyperinsulinism

NCT03117517 2020-03-02

Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome

Khyber Medical University Peshawar

Phase EARLY_PHASE1 Completed
106 enrolled 7 charts

Polycystic Ovary Syndrome

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed
90 enrolled

Inflammation, Polycystic Ovary Syndrome

NCT00867126 2018-11-26

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Terminated
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡